A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)

By von Minckwitz Gunter   Conrad Bettina   Reimer Toralf   Decker Thomas   Eidtmann Holger   Eiermann Wolfgang   Hackmann John   Möbus Volker   Marmé Frederik   Potenberg Jochem   Stickeler Elmar   Simon Eike   Thomssen Christoph   Huober Jens   Denkert Carsten   Alfer Joachim   Jackisch Christian   Nekljudova Valentina   Burchardi Nicole   Loibl Sibylle   von Minckwitz Gunter  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3639-3648

Blackwell Publishing

Access to resources Recommend Favorite

Ramipril: A Review of its Use in Preventing Cardiovascular Outcomes in High-Risk Patients

By Anderson Vanessa R.   Perry Caroline M.   Robinson Dean M.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 6, 2006-01 ,pp. : 417-432

Adis International

Access to resources Recommend Favorite

Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy

By  

Cancer, Vol. 121, Iss. 14, 2015-07 ,pp. : 2465-2473

Blackwell Publishing

Access to resources Recommend Favorite

The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancer

By Abern Michael R.   Terris Martha K.   Aronson William J.   Kane Christopher J.   Amling Christopher L.   Cooperberg Matthew R.   Freedland Stephen J.  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1656-1662

Blackwell Publishing

Access to resources Recommend Favorite

Perioperative use of low-dose dopexamine reduces mortality and duration of hospital stay in high-risk patients undergoing major surgery

By  

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite